Page 51 - 2023 Taiwan Food and Drug Administration Annual Report

3Advancement of Drug
Figure 3-1 10th Joint Conference of Taiwan and Japan on Medical Products Regulation
▍ Achievements and Benefits
I. Contributed to ICH-related
meetings
As of the end of 2022, TFDA had selected
45 experts to join 28 ICH expert working
groups and they attended phone conferences of
expert working groups more than 196 times.
They prepared the ICH Guidance together
with international experts. Besides proactively industry, the government, and the academia; it
making contributions, continuous efforts
are made to build a regulatory setting that is
internationally competitive.
II. Promoted cooperation
and interaction of
Management
pharmaceutical management
in the Asia-Pacific region
Through the APEC Workshop, proactive
efforts were made to promote regional
harmonization in laws and regulations and
ideas about GRM, advance talent construction
and international collaboration and
exchange, and provide a platform that allows
communications and conversations among the
helps reinforce the overall medicinal capacity
in our country. Throughout 2022, 104 seed
teachers from the industry, the government, and
academia in 12 APEC economies were trained.
III. Reinforced bilateral medical
interaction between Taiwan
49